102 related articles for article (PubMed ID: 15803144)
1. Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo.
Leng Q; Mixson AJ
Cancer Gene Ther; 2005 Aug; 12(8):682-90. PubMed ID: 15803144
[TBL] [Abstract][Full Text] [Related]
2. Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.
Leng Q; Scaria P; Lu P; Woodle MC; Mixson AJ
Cancer Gene Ther; 2008 Aug; 15(8):485-95. PubMed ID: 18483501
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
Sun P; Yu H; Zhang WQ; Hu M; Lv R
Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis and tumor growth in gastric cancer.
Meng F; Dong B; Li H; Fan D; Ding J
Cancer Biol Ther; 2009 Jan; 8(2):174-9. PubMed ID: 19029826
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
6. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models.
Mewani RR; Tang W; Rahman A; Dritschilo A; Ahmad I; Kasid UN; Gokhale PC
Int J Oncol; 2004 May; 24(5):1181-8. PubMed ID: 15067340
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells.
Mewani RR; Tian S; Li B; Danner MT; Carr TD; Lee S; Rahman A; Kasid UN; Jung M; Dritschilo A; Gokhale PC
Int J Mol Med; 2006 Mar; 17(3):457-63. PubMed ID: 16465392
[TBL] [Abstract][Full Text] [Related]
8. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
[TBL] [Abstract][Full Text] [Related]
10. Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo.
Zhang ZH; Chen Y; Zhao HJ; Xie CY; Ding J; Hou YT
Cancer Biol Ther; 2007 Apr; 6(4):587-95. PubMed ID: 17457040
[TBL] [Abstract][Full Text] [Related]
11. Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition.
Chou ST; Leng Q; Scaria P; Kahn JD; Tricoli LJ; Woodle M; Mixson AJ
Biomacromolecules; 2013 Mar; 14(3):752-60. PubMed ID: 23360232
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
14. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
15. Effects of Raf-1 siRNA on human cerebral microvascular endothelial cells: a potential therapeutic strategy for inhibition of tumor angiogenesis.
Culmsee C; Gasser E; Hansen S; Tonn JC; Wagner E; Goldbrunner R
Brain Res; 2006 Dec; 1125(1):147-54. PubMed ID: 17112483
[TBL] [Abstract][Full Text] [Related]
16. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
17. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
18. A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells.
Hofmann MH; Heinrich J; Radziwill G; Moelling K
Mol Cancer Res; 2009 Oct; 7(10):1635-44. PubMed ID: 19825990
[TBL] [Abstract][Full Text] [Related]
19. [Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3].
Yang Z; Yan L; Zhang F; Yan QH; Song WQ; Wang FA; Cai JH
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):819-24. PubMed ID: 21223686
[TBL] [Abstract][Full Text] [Related]
20. c-raf-1 depletion and tumor responses in patients treated with the c-raf-1 antisense oligodeoxynucleotide ISIS 5132 (CGP 69846A).
O'Dwyer PJ; Stevenson JP; Gallagher M; Cassella A; Vasilevskaya I; Monia BP; Holmlund J; Dorr FA; Yao KS
Clin Cancer Res; 1999 Dec; 5(12):3977-82. PubMed ID: 10632328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
